Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
1960 1
1961 1
1964 1
1966 1
1967 1
1968 1
1969 3
1970 3
1971 2
1972 5
1974 4
1975 1
1976 3
1977 3
1978 5
1979 5
1980 3
1981 4
1982 7
1983 5
1984 7
1985 4
1986 4
1987 5
1988 13
1989 9
1990 7
1991 7
1992 8
1993 15
1994 16
1995 15
1996 18
1997 23
1998 20
1999 17
2000 17
2001 14
2002 12
2003 8
2004 12
2005 11
2006 4
2007 2
2008 9
2009 11
2010 6
2011 3
2012 4
2013 5
2014 2
2015 4
2016 7
2017 6
2020 3
2022 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators. Montalban X, et al. N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002688 Free article. Clinical Trial.
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. McDonald WI, et al. Among authors: mcfarland hf. Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032. Ann Neurol. 2001. PMID: 11456302
Introduction to the Special Issue.
McFarland H, Reich DS, Jacobson S. McFarland H, et al. J Neuroimmunol. 2017 Mar 15;304:1. doi: 10.1016/j.jneuroim.2017.01.022. Epub 2017 Feb 3. J Neuroimmunol. 2017. PMID: 28214502 Free PMC article. No abstract available.
Skin allograft rejection.
McFarland HI, Rosenberg AS. McFarland HI, et al. Curr Protoc Immunol. 2009 Feb;Chapter 4:4.4.1-4.4.13. doi: 10.1002/0471142735.im0404s84. Curr Protoc Immunol. 2009. PMID: 19235769
Immunology of multiple sclerosis.
McFarland HF. McFarland HF. Ann N Y Acad Sci. 1988;540(1):99-105. doi: 10.1111/j.1749-6632.1988.tb27055.x. Ann N Y Acad Sci. 1988. PMID: 2974693 Free PMC article. Review. No abstract available.
Megadose corticosteroids in multiple sclerosis.
Kupersmith MJ, Kaufman D, Paty DW, Ebers G, McFarland H, Johnson K, Reingold S, Whitaker J. Kupersmith MJ, et al. Among authors: mcfarland h. Neurology. 1994 Jan;44(1):1-4. doi: 10.1212/wnl.44.1.1. Neurology. 1994. PMID: 8290041 No abstract available.
Multiple sclerosis (second of two parts).
McFarlin DE, McFarland HF. McFarlin DE, et al. Among authors: mcfarland hf. N Engl J Med. 1982 Nov 11;307(20):1246-51. doi: 10.1056/NEJM198211113072005. N Engl J Med. 1982. PMID: 6290885 Review. No abstract available.
Multiple sclerosis (first of two parts).
McFarlin DE, McFarland HF. McFarlin DE, et al. Among authors: mcfarland hf. N Engl J Med. 1982 Nov 4;307(19):1183-8. doi: 10.1056/NEJM198211043071905. N Engl J Med. 1982. PMID: 6750404 Review. No abstract available.
Immunological aspects of demyelinating diseases.
Martin R, McFarland HF, McFarlin DE. Martin R, et al. Among authors: mcfarland hf. Annu Rev Immunol. 1992;10:153-87. doi: 10.1146/annurev.iy.10.040192.001101. Annu Rev Immunol. 1992. PMID: 1375472 Review.
383 results